SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-010402
Filing Date
2021-03-29
Accepted
2021-03-29 10:23:28
Documents
14
Period of Report
2021-03-26
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10022399_8k.htm   iXBRL 8-K 28310
2 EXHIBIT 3.1 brhc10022399_ex3-1.htm EX-3.1 221938
3 EXHIBIT 14.1 brhc10022399_ex14-1.htm EX-14.1 102773
  Complete submission text file 0001140361-21-010402.txt   549785

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ions-20210326.xsd EX-101.SCH 4204
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20210326_lab.xml EX-101.LAB 23469
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20210326_pre.xml EX-101.PRE 16736
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10022399_8k_htm.xml XML 4239
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 21779905
SIC: 2834 Pharmaceutical Preparations